Nalaganje...
Molecular targets in heart failure gene therapy: current controversies and translational perspectives
Gene therapy of heart failure is gaining momentum as a result of the recent successful completion of phase II of the CUPID trial, which showed clinical safety and efficacy of an adeno-associated viral vector expressing SERCA2a. Resorting to gene therapy allows the manipulation of molecular targets n...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3470446/ https://ncbi.nlm.nih.gov/pubmed/22548568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1749-6632.2012.06520.x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|